KR100360639B1 - N-치환글리신함유브라디키닌길항제펩티드 - Google Patents

N-치환글리신함유브라디키닌길항제펩티드 Download PDF

Info

Publication number
KR100360639B1
KR100360639B1 KR1019960704967A KR19960704967A KR100360639B1 KR 100360639 B1 KR100360639 B1 KR 100360639B1 KR 1019960704967 A KR1019960704967 A KR 1019960704967A KR 19960704967 A KR19960704967 A KR 19960704967A KR 100360639 B1 KR100360639 B1 KR 100360639B1
Authority
KR
South Korea
Prior art keywords
arg
gly
hyp
ser
pro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1019960704967A
Other languages
English (en)
Korean (ko)
Inventor
발 에스. 굿펠로우
마노즈 브이. 마라테
에릭 티. 홀리
티모시 디. 피츠패트릭
카렌 지. 쿨만
Original Assignee
코르텍, 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 코르텍, 인크. filed Critical 코르텍, 인크.
Application granted granted Critical
Publication of KR100360639B1 publication Critical patent/KR100360639B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/18—Kallidins; Bradykinins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
KR1019960704967A 1994-03-09 1995-03-07 N-치환글리신함유브라디키닌길항제펩티드 Expired - Fee Related KR100360639B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20811594A 1994-03-09 1994-03-09
US08/208,115 1994-03-09

Publications (1)

Publication Number Publication Date
KR100360639B1 true KR100360639B1 (ko) 2003-01-30

Family

ID=22773240

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019960704967A Expired - Fee Related KR100360639B1 (ko) 1994-03-09 1995-03-07 N-치환글리신함유브라디키닌길항제펩티드

Country Status (12)

Country Link
US (1) US5700779A (enExample)
EP (1) EP0813544B1 (enExample)
JP (1) JPH09511500A (enExample)
KR (1) KR100360639B1 (enExample)
CN (1) CN1150206C (enExample)
AT (1) ATE280777T1 (enExample)
AU (1) AU696429B2 (enExample)
CA (1) CA2184824A1 (enExample)
DE (1) DE69533704D1 (enExample)
TW (1) TW408133B (enExample)
WO (1) WO1995024422A1 (enExample)
ZA (1) ZA951974B (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648336A (en) * 1994-11-18 1997-07-15 University Of Colorado Bradykinin antagonist peptides containing indane-substituted amino acids
WO1996039425A2 (en) * 1995-06-05 1996-12-12 Cortech, Inc. Compounds having bradykinin antagonistic activity and mu-opioid agonistic activity
US5849863A (en) * 1995-09-08 1998-12-15 University Of Colorado Cytolytic bradykinin antagonists
DE19612067A1 (de) * 1996-03-27 1997-10-02 Hoechst Ag Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von chronisch fibrogenetischen Lebererkrankungen und akuten Lebererkrankungen
FR2756566B1 (fr) * 1996-12-04 1999-01-08 Fournier Ind & Sante Peptides agonistes du recepteur b2 de la bradykinine, procede de preparation et utilisation en therapeutique
US6849605B1 (en) 1999-03-05 2005-02-01 The Trustees Of University Technology Corporation Inhibitors of serine protease activity, methods and compositions for treatment of viral infections
AU3511500A (en) 1999-03-05 2000-09-21 Trustees Of University Technology Corporation, The Inhibitors of serine protease activity, methods and compositions for treatment of nitric oxide-induced clinical conditions
AU3731400A (en) 1999-03-05 2000-09-21 Trustees Of University Technology Corporation, The Methods and compositions useful in inhibiting apoptosis
AU3864000A (en) * 1999-03-05 2000-09-21 Trustees Of University Technology Corporation, The Inhibitors of serine protease activity, methods and compositions for treatment of herpes viruses
US7105172B1 (en) 1999-11-18 2006-09-12 Bolla John D Treatment of rosacea
US6699486B1 (en) 1999-11-18 2004-03-02 Bolla Corporation Treatment or prevention of photoaging and skin cancer
US7211566B2 (en) * 2003-04-01 2007-05-01 Universite De Sherbrooke Selective bradykinin (BK) B1 peptidic receptor antagonists and uses thereof
US20040220242A1 (en) * 2003-05-02 2004-11-04 Leland Shapiro Inhibitors of serine protease activity, methods and compositions for treatment of nitric oxide induced clinical conditions
US7605120B2 (en) * 2003-10-22 2009-10-20 Amgen Inc. Antagonists of the brandykinin B1 receptor
US7932228B2 (en) * 2004-08-19 2011-04-26 Societe de Commercialisation des Produits de la Recherche Applique Socpra Sciences Sante et Humaines S.E.C. Method of treating bone or prostate cancer with selective bradykinin B1 receptor antagonists
JP2008539260A (ja) * 2005-04-25 2008-11-13 アムジエン・インコーポレーテツド ポロゲンを含む生分解性プチド徐放性組成物
US7403325B2 (en) * 2006-05-19 2008-07-22 Xerox Corporation Electrophoretic display device
US8476408B2 (en) * 2008-06-13 2013-07-02 Alize Pharma Sas Unacylated ghrelin and analogs as therapeutic agents for vascular remodeling in diabetic patients and treatment of cardiovascular disease
FR2974182B1 (fr) * 2011-04-14 2013-04-26 Univ Grenoble 1 Diagnostic et traitement de l'angioedeme
CN102295711A (zh) * 2011-08-23 2011-12-28 湖北宝迪农业科技有限公司 从猪肺中提取肝素钠并联产多肽蛋白粉的工艺
WO2013043669A1 (en) * 2011-09-21 2013-03-28 The Board Of Regents Of The University Of Texas System Peptoid compositions for the treatment of alzheimer's disease and polyglutamine expansion disorder
MX391259B (es) 2015-10-14 2025-03-21 X Therma Inc Composiciones y métodos para reducir la formación de cristales de hielo.
CN116554267A (zh) * 2022-01-30 2023-08-08 江苏众红生物工程创药研究院有限公司 聚乙二醇修饰的激肽或其变体和药物应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1980000252A1 (en) * 1978-07-18 1980-02-21 Kabi Ab Bradykinin-inhibiting tripeptide derivatives
US4693993A (en) * 1985-06-13 1987-09-15 Stewart John M Bradykinin antagonist peptides
IE63490B1 (en) * 1988-11-24 1995-05-03 Hoechst Ag Peptides having bradykinin antagonist action
DE4013270A1 (de) * 1990-04-26 1991-10-31 Hoechst Ag Peptide mit bradykinin-antagonistischer wirkung
CA2106768C (en) * 1991-04-19 2000-09-19 Donald J. Kyle Bradykinin type peptides
EP0529499A1 (de) * 1991-08-22 1993-03-03 Hoechst Aktiengesellschaft Pharmazeutische Zusammensetzungen enthaltend Bradykinin-Antagonisten zur lokalen Anwendung an Nase und Auge
WO1993011789A1 (en) * 1991-12-12 1993-06-24 Scios Nova Inc. Modified position (7) bradykinin antagonist peptides
TW258739B (enExample) * 1992-04-04 1995-10-01 Hoechst Ag
ES2148347T3 (es) * 1993-09-09 2000-10-16 Scios Inc Antagonistas del receptor de la bradiquinina pseudo y no peptidica.

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
일본공개특허공보 평2-184,697호 (1990.7.19.). *

Also Published As

Publication number Publication date
DE69533704D1 (de) 2004-12-02
EP0813544A4 (enExample) 1998-01-07
AU696429B2 (en) 1998-09-10
JPH09511500A (ja) 1997-11-18
ATE280777T1 (de) 2004-11-15
WO1995024422A1 (en) 1995-09-14
CN1148393A (zh) 1997-04-23
TW408133B (en) 2000-10-11
EP0813544B1 (en) 2004-10-27
EP0813544A1 (en) 1997-12-29
CN1150206C (zh) 2004-05-19
US5700779A (en) 1997-12-23
CA2184824A1 (en) 1995-09-14
ZA951974B (en) 1995-12-11
AU1932595A (en) 1995-09-25

Similar Documents

Publication Publication Date Title
KR100360639B1 (ko) N-치환글리신함유브라디키닌길항제펩티드
CA2140543C (en) Thrombin receptor antagonists
US5506206A (en) Increasing blood-brain barrier permeability with permeabilizer peptides
US6388054B1 (en) Anti-cancer compounds
KR0181512B1 (ko) 펩티드 아미드, 이의 제조방법 및 피브린/트롬빈 응고 억제제로서 사용하기 위한 이를 함유하는 약제학적 조성물
SK13082001A3 (sk) Cyklický peptidový analóg a jeho výroba
US5610140A (en) Bradykinin receptor antagonists with neurokinin receptor blocking activity
HUT74731A (en) Novel opioid peptides for the treatment of pain and use thereof
JPH0680079B2 (ja) ポリペプチド
JP4563806B2 (ja) Ｐ−セレクチンに対する結合性化合物
US5786335A (en) Sulfhydryl containing peptides for treating vascular disease
JP2949129B2 (ja) 胃腸運動刺激活性を有するモチリン類似ポリペプチド
WO1993000359A1 (en) Modified peptides transportable into the central nervous system
EP0755942B1 (en) N-amidino dermorphin derivative
US6051685A (en) Peptide derivatives
JPH0262559B2 (enExample)
EP1906988A2 (en) Synthetic peptide inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4
JPH04501710A (ja) 新規なペンタペプチドおよびその製造方法
US5276137A (en) Analgesic peptides with a trifluoronorvaline modification
CA1180006A (en) Therapeutically useful pseudopeptides, compositions containing the same and methods of preparation and use
JP2000503649A (ja) 抗血栓剤および使用法
JP2553506B2 (ja) ポリペプチド
JP2513440B2 (ja) 新規ペプチド
US20010007016A1 (en) Peptide derivatives
MXPA96003970A (en) Peptidos broniquinin antagonists that incorporate n-substitute glycines

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20051030

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20051030